| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |